Da Hee Han, PharmD

All articles by Da Hee Han, PharmD

FDA: No CV advantage with naproxen

Oral NSAIDs for Knee OA: Duration of Efficacy, Time to Adverse Event Onset Examined

A systematic review and meta-analysis published in Arthritis Care & Research aimed to assess the duration of efficacy, as well as the onset of adverse events, associated with oral nonsteroidal anti-inflammatory drugs (NSAIDS) used in the treatment of knee osteoarthritis (OA). To investigate these outcomes, researchers conducted a literature search which identified 72 randomized controlled…

Next post in Migraine & Headache